Evidence map›Paper›PMID 28444175›Full record

ArticleEuropean heart journal2017

Predictive value of telomere length on outcome following acute myocardial infarction: evidence for contrasting effects of vascular vs. blood oxidative stress.

Marios Margaritis, Fabio Sanna, George Lazaros, Ioannis Akoumianakis, Sheena Patel, Alexios S Antonopoulos, Chloe Duke, Laura Herdman, Costas Psarros, Evangelos K Oikonomou and 8 more

Registry-linked trialOpen access · hybridAbstract readComparative Study
In one paragraph

Article in European heart journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06557811 (Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06557811 phase4not yet recruitingstarted 2024, after this paper: background citation

Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction: a Randomized and Double-blind Clinical Trial

Ran2024Enrolled88Registered outcomes26Posted comparisons0ConditionsAcute Myocardial Infarction, Diabetic PatientsArmssemaglutide
Open the trial in the graph
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Marios MargaritisCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Fabio SannaCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
George Lazaros1st Department of Cardiology, Hippokrateion Hospital, University of Athens, Vas Sofias 114, 11527, Athens, Greece.
Ioannis AkoumianakisCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Sheena PatelCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Alexios S AntonopoulosCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Chloe DukeCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Laura HerdmanCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Costas PsarrosCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Evangelos K OikonomouCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Cheerag ShirodariaCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Mario PetrouDepartment of Cardiac Surgery, Oxford Heart Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK.
Rana SayeedDepartment of Cardiac Surgery, Oxford Heart Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK.
George KrasopoulosDepartment of Cardiac Surgery, Oxford Heart Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK.
Regent LeeCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Dimitris Tousoulis1st Department of Cardiology, Hippokrateion Hospital, University of Athens, Vas Sofias 114, 11527, Athens, Greece.
Keith M ChannonCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
Charalambos AntoniadesCardiovascular Medicine Division, University of Oxford, John Radcliffe Hospital, West Wing L6, Headley Way, Oxford OX3 9DU, UK.
John Radcliffe Hospital · GBUniversity of Oxford · GBNational and Kapodistrian University of Athens · GR

Funding

British Heart Foundation FS/16/15/32047British Heart Foundation PG/13/56/30383British Heart Foundation RG/07/003/23133British Heart Foundation RG/12/5/29576British Heart Foundation RG/17/10/32859
6 · The paper itself

Abstract

aimsExperimental evidence suggests that telomere length (TL) is shortened by oxidative DNA damage, reflecting biological aging. We explore the value of blood (BTL) and vascular TL (VTL) as biomarkers of systemic/vascular oxidative stress in humans and test the clinical predictive value of BTL in acute myocardial infarction (AMI). METHODS AND

resultsIn a prospective cohort of 290 patients surviving recent AMI, BTL measured on admission was a strong predictor of all-cause [hazard ratio (HR) [95% confidence interval (CI)]: 3.21 [1.46-7.06], P = 0.004] and cardiovascular mortality (HR [95% CI]: 3.96 [1.65-9.53], P = 0.002) 1 year after AMI (for comparisons of short vs. long BTL, as defined by a T/S ratio cut-off of 0.916, calculated using receiver operating characteristic analysis; P adjusted for age and other predictors). To explore the biological meaning of these findings, BTL was quantified in 727 consecutive patients undergoing coronary artery bypass grafting (CABG), and superoxide (O2.-) was measured in peripheral blood mononuclear cells (PBMNC). VTL/vascular O2.- were quantified in saphenous vein (SV) and mammary artery (IMA) segments. Patients were genotyped for functional genetic polymorphisms in P22ph°x (activating NADPH-oxidases) and vascular smooth muscle cells (VSMC) selected by genotype were cultured from vascular tissue. Short BTL was associated with high O2.- in PBMNC (P = 0.04) but not in vessels, whereas VTL was related to O2.- in IMA (ρ = -0.49, P = 0.004) and SV (ρ = -0.52, P = 0.01). Angiotensin II (AngII) incubation of VSMC (30 days), as a means of stimulating NADPH-oxidases, increased O2.- and reduced TL in carriers of the high-responsiveness P22ph°x alleles (P = 0.007).

conclusionBTL predicts cardiovascular outcomes post-AMI, independently of age, whereas VTL is a tissue-specific (rather than a global) biomarker of vascular oxidative stress. The lack of a strong association between BTL and VTL reveals the importance of systemic vs. vascular factors in determining clinical outcomes after AMI.

Indexed as

AgedBiomarkersCardiovascular DiseasesFemaleHumansLeukocytes, MononuclearMaleMammary ArteriesMiddle AgedMuscle, Smooth, VascularMyocardial InfarctionNADPH OxidasesOxidative StressPolymorphism, GeneticPrognosisProspective StudiesBiomarkersNADPH OxidasesSuperoxidesNADPH-oxidasesPost-procedural outcomeSuperoxideTelomere length

Identifiers

PMID28444175
PMCPMC5837455
OpenAlexW2609522009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.